Advair HFA (Fluticasone-Salmeterol HFA)

Approved for Maintenance treatment of asthma in patients aged 12 years and older. Combines fluticasone propionate (inhaled corticosteroid) and salmeterol (long-acting beta-2 agonist) in a metered-dose inhaler formulation. Dual mechanism addresses both inflammation and… Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS NADAC…

Loading full data from Know Your Drugs Institute…